NFG
NBIX icon

Next Financial Group’s Neurocrine Biosciences NBIX Stock Holding History

Next Financial Group’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$423K Buy
4,968
+1,341
+37% +$123K 0.03% 617
2021
Q3 		$348K Buy
3,627
+713
+24% +$67.3K 0.03% 604
2021
Q2 		$284K Sell
2,914
-310
-10% -$29.7K 0.02% 705
2021
Q1 		$314K Buy
3,224
+208
+7% +$21.8K 0.03% 612
2020
Q4 		$289K Buy
3,016
+860
+40% +$83.1K 0.03% 576
2020
Q3 		$208K Buy
+2,156
New +$249K 0.02% 603
2020
Q2 		– Sell
-630
Closed -$55K – 1415
2020
Q1 		$55K Hold
630
– – 0.01% 961
2019
Q4 		$68K Buy
630
+70
+13% +$7.33K 0.01% 1081
2019
Q3 		$50K Hold
560
– – 0.01% 1148
2019
Q2 		$47K Buy
560
+265
+90% +$21.8K 0.01% 1188
2019
Q1 		$26K Hold
295
– – 0.01% 896
2018
Q4 		$21K Sell
295
-100
-25% -$9.58K ﹤0.01% 1075
2018
Q3 		$49K Buy
+395
New +$44.8K 0.02% 553
2017
Q4 		– Sell
-275
Closed -$17K – 983
2017
Q3 		$17K Buy
275
+175
+175% +$9.23K ﹤0.01% 1027
2017
Q2 		$5K Buy
+100
New +$4.85K ﹤0.01% 1547
2017
Q1 		– Sell
-230
Closed -$9K – 2131
2016
Q4 		$9K Hold
230
– – ﹤0.01% 1698
2016
Q3 		$12K Buy
+230
New +$11.5K ﹤0.01% 1588
2014
Q4 		– Sell
-430
Closed -$7K – 2181
2014
Q3 		$7K Buy
+430
New +$6.43K ﹤0.01% 1935

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Next Financial Group's NBIX Position: Q4 2021 in Review

Next Financial Group increased its Neurocrine Biosciences (NBIX) stake by 37% in Q4 2021, buying an estimated $123K and bringing the position to 4,968 shares worth $423K. The position accounts for 0.03% of the portfolio, ranked #617.

Next Financial Group first reported a position in NBIX in Q3 2014 and has held it in 18 quarters since. 405 funds tracked by Wall St. Rank hold NBIX as of Q4 2021.

  • Next Financial Group held 4,968 shares of Neurocrine Biosciences worth $423K as of Q4 2021.
  • Next Financial Group bought 1,341 Neurocrine Biosciences shares in Q4 2021, an estimated $123K.
  • Neurocrine Biosciences made up 0.03% of Next Financial Group's portfolio in Q4 2021, its #617 holding.
  • Next Financial Group first reported a position in Neurocrine Biosciences in Q3 2014 and has held it in 18 quarters since.
  • 405 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.